[
    [
        {
            "time": "2018-03-01",
            "original_text": "巨丰哥问答：近期港股上涨迅猛原因何在？",
            "features": {
                "keywords": [
                    "港股",
                    "上涨",
                    "原因"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "巨丰哥问答：近期港股上涨迅猛原因何在？",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-03-01",
            "original_text": "【调研最前线】诺思兰德(430047)：立足心血管，做重组蛋白与基因治疗药物开拓者",
            "features": {
                "keywords": [
                    "诺思兰德",
                    "心血管",
                    "重组蛋白",
                    "基因治疗"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【调研最前线】诺思兰德(430047)：立足心血管，做重组蛋白与基因治疗药物开拓者",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-03-01",
            "original_text": "收评:沪指走强涨0.44% 创业板涨2.07%豪取4连阳",
            "features": {
                "keywords": [
                    "沪指",
                    "创业板",
                    "连阳"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "收评:沪指走强涨0.44% 创业板涨2.07%豪取4连阳",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-03-01",
            "original_text": "午评：沪指反转走强涨0.60% 工业互联网领涨两市",
            "features": {
                "keywords": [
                    "沪指",
                    "工业互联网",
                    "领涨"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "工业互联网"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "午评：沪指反转走强涨0.60% 工业互联网领涨两市",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-03-01",
            "original_text": "晨会聚焦180301：重点关注美亚柏科、广联达、石基信息、天虹股份、乐普医疗、扬杰科技",
            "features": {
                "keywords": [
                    "美亚柏科",
                    "广联达",
                    "石基信息",
                    "天虹股份",
                    "乐普医疗",
                    "扬杰科技"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "科技",
                    "医药",
                    "零售"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "晨会聚焦180301：重点关注美亚柏科、广联达、石基信息、天虹股份、乐普医疗、扬杰科技",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-03-01",
            "original_text": "郭广昌在法国接受采访：复星正瞄准更多海外交易",
            "features": {
                "keywords": [
                    "郭广昌",
                    "复星",
                    "海外交易"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "郭广昌在法国接受采访：复星正瞄准更多海外交易",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-02-28",
            "original_text": "中泰证券3月各行业观点及重点推荐标的-20180228",
            "features": {
                "keywords": [
                    "中泰证券",
                    "行业观点",
                    "推荐标的"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "中泰证券3月各行业观点及重点推荐标的-20180228",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-03-01",
            "original_text": "【医药】江琦：医药生物行业2018年3月月报：以业绩为导向，以创新为方向-20180301",
            "features": {
                "keywords": [
                    "医药生物",
                    "业绩",
                    "创新"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【医药】江琦：医药生物行业2018年3月月报：以业绩为导向，以创新为方向-20180301",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]